The present invention relates to fusion peptides comprising fragments of the cancer-related protein Her2/neu, methods of preparing such fusion peptides, delivery systems associated with such fusion peptides, compositions comprising such fusion peptides and/or delivery systems, and medical uses of such fusion peptides, delivery systems and/or compositions for the prevention, treatment and/or amelioration of a cancer associated with expression or over-expression of the Her2/neu protein.
